These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 12684629)

  • 21. [Promising new drugs for gynecological cancer].
    Yakushiji M; Sugiyama T; Ushijima K
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1932-7. PubMed ID: 9350238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of irinotecan (CPT-11) and nedaplatin (NDP) for recurrent patients with uterine cervical cancer.
    Ohara T; Kobayashi Y; Yoshida A; Yoshioka N; Yahagi N; Kondo H; Tozawa A; Kiguchi K; Suzuki N
    Int J Clin Oncol; 2013 Dec; 18(6):1102-6. PubMed ID: 23095879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Irinotecan hydrochloride (CPT-11) for advanced cervical cancer].
    Terauchi F
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():175-8. PubMed ID: 15535228
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of antitumor activity of etoposide administered orally for 21 consecutive days against human uterine cancer subcutaneous and/or orthotopic xenografts in nude mice].
    Matsumoto S; Mashiba H; Okamoto K; Ekimoto H
    Gan To Kagaku Ryoho; 1999 Aug; 26(9):1313-20. PubMed ID: 10478185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor effect of NK012, a 7-ethyl-10-hydroxycamptothecin-incorporating polymeric micelle, on U87MG orthotopic glioblastoma in mice compared with irinotecan hydrochloride in combination with bevacizumab.
    Kuroda J; Kuratsu J; Yasunaga M; Koga Y; Kenmotsu H; Sugino T; Matsumura Y
    Clin Cancer Res; 2010 Jan; 16(2):521-9. PubMed ID: 20068081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
    Adachi S; Ogasawara T; Tsubamoto H; Oku H; Hori Y; Tsuji Y; Takemura T; Koyama K
    Int J Clin Pharmacol Res; 2001; 21(3-4):105-10. PubMed ID: 12067139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational combination therapy of vintafolide (EC145) with commonly used chemotherapeutic drugs.
    Reddy JA; Dorton R; Bloomfield A; Nelson M; Vetzel M; Guan J; Leamon CP
    Clin Cancer Res; 2014 Apr; 20(8):2104-14. PubMed ID: 24429878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor effect of CPT-11, a camptothecin derivative, on human testicular tumor xenografts in nude mice.
    Miki T; Sawada M; Nonomura N; Kojima Y; Okuyama A; Maeda O; Saiki S; Kotake T
    Eur Urol; 1997; 31(1):92-6. PubMed ID: 9032542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].
    Noda K; Hirabayashi K; Terashima Y; Ozaki M; Yakushiji M; Hatae M; Kanazawa K
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1285-93. PubMed ID: 9279348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Augmented antitumor efficacy of combination chemotherapy of nedaplatin with 5-fluorouracil in in vivo murine and human tumor model].
    Uchida N; Takeda Y; Kasai H; Hojo K; Wada T; Nishida K; Maekawa R; Sugita K; Yoshioka T
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2267-74. PubMed ID: 9881084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined irinotecan (CPT-11) and nedaplatin (254-S) therapy for advanced and/or recurrent cervical cancer].
    Hiruma R; Kamide T; Anzai N; Matsumoto R; Kotake Y; Wachi T; Shinozaki H; Tada A; Kamiya N; Sasaki H
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):607-10. PubMed ID: 18408429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Augmented antitumor activity in combination chemotherapy of nedaplatin with etoposide].
    Uchida N; Kasai H; Takeda Y; Maekawa R; Sugita K; Yoshioka T
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):79-87. PubMed ID: 9464333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical effects of combination chemotherapy with irinotecan hydrochloride and cisplatin on cervical cancer: study of 46 patients].
    Wang CY; Ma D; Zhu T; Chen SY; Zhang QH; Song XJ; Chen TH; Gu MJ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2104-8. PubMed ID: 16313818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Successful downstaging by a low-dose, fractional administration of irinotecan hydrochloride (CPT-11) in combination with cisplatin in peritoneal lavage cytology positive, 5-fluorouracil refractory advanced gastric cancer patients].
    Shimoyama S; Imamura K; Katayama A; Hiki N; Shimizu N; Yamaguchi H; Mafune K; Motoi T; Oohashi K; Kaminishi M
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):929-32. PubMed ID: 15222115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil.
    Nakajima TE; Yasunaga M; Kano Y; Koizumi F; Kato K; Hamaguchi T; Yamada Y; Shirao K; Shimada Y; Matsumura Y
    Int J Cancer; 2008 May; 122(9):2148-53. PubMed ID: 18196580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro augmentation of antitumor effect in combination with CPT-11 and CDDP for human colorectal cancer.
    Tsunoda T; Tanimura H; Hotta T; Tani M; Iwahashi M; Ishimoto K; Tanaka H; Matsuda K; Yamaue H
    J Surg Oncol; 2000 Jan; 73(1):6-11. PubMed ID: 10649271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer.
    Shinkai T; Arioka H; Kunikane H; Eguchi K; Sasaki Y; Tamura T; Ohe Y; Oshita F; Nishio M; Karato A
    Cancer Res; 1994 May; 54(10):2636-42. PubMed ID: 8168091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of in vivo antitumor activity of classical anticancer agents by combination with the new, glutathione-interacting DNA minor groove-binder, brostallicin.
    Sabatino MA; Colombo T; Geroni C; Marchini S; Broggini M
    Clin Cancer Res; 2003 Nov; 9(14):5402-8. PubMed ID: 14614026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activity of IHL-305, a novel pegylated liposome containing irinotecan, in human xenograft models.
    Matsuzaki T; Takagi A; Furuta T; Ueno S; Kurita A; Nohara G; Kodaira H; Sawada S; Hashimoto S
    Oncol Rep; 2012 Jan; 27(1):189-97. PubMed ID: 21935577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.
    Oliver PG; LoBuglio AF; Zinn KR; Kim H; Nan L; Zhou T; Wang W; Buchsbaum DJ
    Clin Cancer Res; 2008 Apr; 14(7):2180-9. PubMed ID: 18381960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.